A potent inhibitor of microbial serine proteases, including subtilisin, has been purified 1100-fold from seeds of broad bean (Vicia faba, cv. Kleine Thtiringer). Chymotrypsin and trypsin were not inhibited, but a weak "temporary" inhibition of pancreas elastase was observed. The preparation of pure inhibitor contained one major molecular form with a blocked N-terminal (MW -10,000, pl -4.8) and a minor form ( < 10%) with slightly lower MW and pl -5.0. About 80% of the amino acid sequence of the major form was determined by automatic Edman degradation of a cyanogen bromide fragment and tryptic peptides. The inhibitor is homologous with barley, potato and leech inhibitors of the "potato inhibitor I family" (36-56% of the amino acid residues in identical positions). Cleavage studies suggest one enzyme inhibitory site at an Ala-Asp bond.
INTRODUCTION
Leguminous seed inhibitors of trypsin and chymotrypsin, classified in the "Bowman-Birk and Kunitz plant inhibitor families" (7) , are among the best characterized plant proteins. lsoelectric focusing has, however, shown that all legume seeds tested also contain significant amounts of one or two subtilisin inhibitors with Abbreviations: APNE = N-acetyl-D,L-phenylalanine-2-naphtyl ester; BAPA = N-Benzoyl-e-arginine-p-nitroanilide; CI-I and CI-2: Chymotrypsin inhibitor 1 and 2 from barley (1, 16) ; EDTA = Ethylenediamine tetraacetate; GPPA = N-glutaryl-e-phenylalanyl p-nitroanilide; HPLC = High performance liquid chromatography; IEF = Isoelectric focusing; LIE = Leech inhibitor eglin (13) ; PAGE = Polyacrylamide gel electrophoresis; PI-I = Potato inhibitor I (11, 12) ; PTH = Phenylthiohydantoin; SAAAPA = N-succinyl-L-alanyl-L-alanyl-L-alanine-p-nitroanilide; SDS = Sodium dodecylsulphate; VSI = Vicia subtilisin inhibitor; ZGGLPA = Carbobenzoxy-glycyl-glycyl-Lleucine-p-nitroanilide; ZPNE = Carbobenzoxy-L-phenylalanine-2-naphthylester. pI 4.5 -6, which are not related to any of these two families of homologous inhibitors (2) . Legume subtilisin inhibitors have, so far, been purified from seeds of black bean (Phaseolus vulgaris) (14) and cowpea (Vigna unguiculata) (19, 20) . Characterization of the Phaseolus inhibitor with respect to disulphide bridges and specificity (15) indicated relations to the "Streptomyces subtilisin inhibitor family" (7) .
In the present study a subtilisin inhibitor was isolated from broad bean (Vicia faba). Characterization, including sequence studies, clearly shows that this legume inhibitor is a member of the "potato inhibitor I family" (7) . The family includes a number of homologous inhibitors from higher plants (16) and one from a lower animal, the leech (13) . These inhibitors are not functionally dependent on the presence of disulphide bridges in their structure (16) . The abbreviation VSI is used for the Vicia subtilisin inhibitor, although characterization of the specificity also showed a weak inhibition of pancreas elastase.
MATERIALS AND METHODS

Materials
Bovine trypsin, bovine chymotrypsin, subtilisin Carlsberg, subtilisin Novo and Bacillus pulimus protease were obtained from Novo Industries, Bagsv~erd, Denmark, Aspergillus oryzae protease from Sigma, St. Louis, USA, and porcine pancreas elastase from Boehringer, Mannheim, GFR. The substrates GPPA and BAPA were from Merck, Darmstadt, GFR, ZPNE from ICN, Cleveland, Ohio, USA, ZGGLPA from Serva, Heidelberg, GFR, SAAAPA from Sigma, St. Louis, USA, and APNE from Bachem, Switzerland. Zwittergent 3-12 was obtained from Calbiochem, Cal., USA. Sephadex G75 and DEAE-Sephadex A50 were products of Pharmacia, Uppsala, Sweden. All chemicals used in the sequencer were from Rathburn, Walkerburn, U.K. except ethylacetate which was a Merck product and Polybrene which was from Pierce, Rochford, USA.
Protease inhibitor assays
During purification inhibition of subtilisin was monitored at 25 ~ by fluorescence spectrophotometry using a cylindrical flow cuvette (Uvicord II, LKB, Sweden) mounted in a Perkin-Elmer 204 fluorescence spectrophotometer. About 0.5 ktg subtilisin Carlsberg was preincubated for 5 min with appropriately diluted inhibitor solution in a final volume of 100 /al 50 mM-phosphate buffer, pH 7.8. A solution of substrate in the same buffer (400 ~tl) was added to give a final concentration of 75 BM-ZPNE dissolved by the presence of 9% dimethylformamide and 0.2% SDS. The mixture was drawn into the cuvette, and increase in fluorescence was registered continuously using ~xc, = 330 nm and L,.a~ = 420 nm. One inhibitor unit was defined as the calculated amount of inhibitor which inactivated 1 mg ofsubtilisin preparation in the assay.
For the specificity studies, inhibition ofserine proteases was determined spectrophotometrically at 410 nm and 25 ~ in 1 ml 50 mM-Tris-HC1, pH 8.0 after 5 min preincubation of enzyme with inhibitor. Residual activity was measured continuously with the following substrates: subtilisin Carlsberg, subtilisin Novo, Bacillus pumilus protease and Aspergillus oryzae protease with 0.18 mM-ZGGLPA, porcine pancreas elastase with 0.1 mM-SAAAPA, bovine chymotrypsin with 0.83 mM-GPPA, and bovine trypsin with 0.5 mM-BAPA.
All enzymes were dissolved in 10 mM-sodium acetate buffer, pH 5.5, and 100 lal was preincubated with 300 ktl inhibitor solution. The most reproducible results were obtained when the final inhibitor dilutions were made with 0.1% Zwittergent 3-12. All assays with ZGGLPA were made in the presence of 9% acetonitrile to keep the substrate dissolved (9) . Assays with the technical grade preparations of proteases from Aspergillus oryzae and Bacillus pumilus were made in the presence of 10 mM-EDTA, an efficient inhibitor of microbial neutral proteases (10).
Extraction and (NH4)~SO4 precipitation
Seeds of broad bean (Vicia faba, cv. Kleine Thuringer) were dehulled manually and ground to a fine flour in a Udy cyclone mill. The flour (250 g) was stirred vigorously with water (2,500 ml) for 2 hours at 20 ~ and the extract was isolated by centrifugation at 10 000 G for 20 min. All subsequent purification steps were performed at 2 -4 ~ After adjustment to 40% saturation with ammonium sulfate the extract was stirred for 2 hours and centrifuged. The concentration of ammonium sulfate in the supernatant solution was increased to 60% saturation, and precipitation of the inhibitor was made overnight. After centrifugation the precipitate was dissolved in 200 ml water and dialyzed against several changes of water followed by 50 mM-Tris-HCl buffer, pH 8.5.
Gel filtration, Sephadex G75
Freeze-dried inhibitor from anion exchange, pH 7.5 (section 2.4.3) was dissolved in 50 mM-phosphate buffer, pH 6.1, containing 0.5 M-NaCI (2 mg/ml). Two ml portions of this solution were applied to a 0.9x 120 cm column of Sephadex G75, and the inhibitor was eluted with the same buffer at a flow rate of 10 mlxh -t and 2 ml fractions were collected. Standardization under the same experimental conditions was made with a mixture of ovalbumin (MW 43,000), carbonic anhydrase (MW 30,000), cytochrome C (MW 12,500), and aprotinin (MW 6,500).
Chromatography
Anion exchange, pH 8.5
After centrifugation the crude inhibitor preparation (section 2.3) was mixed with 200 ml DEAE-Sephadex A 50, which had been swelled and equilibrated in 50 mM-Tris-HC1 buffer, pH 8.5. After gentle shaking overnight the gel was washed with the same buffer on a BiJchner funnel, packed in a 2.5x30 cm column, and the inhibitor was eluted at a rate of 25 mlxh ~ with 1 litre ofa 0 -0.5 M linear gradient of NaC1 in the buffer. After inhibitor assays, pooled fractions were dialyzed against water and freeze-dried.
Gelfiltration, Sephadex G50
The freeze-dried material from anion exchange (section 2.4.1 ) was dissolved in 10 m125 mM-phosphate buffer, pH 7.5, and applied to a 2.5x80 cm column of Sephadex G50. Proteins were eluted with the same buffer at a flow rate of 25 mlxh-'.
Anion exchange, pH 7.5
Pooled fractions from gel filtration (section
2.4.2)
were applied directly to a 1.5• cm column of DEAE-Sephadex. After washing with 25 mM-phosphate buffer, pH 7.5, a 0 -0.2 M linear gradient of NaCl in the buffer was applied at a rate of 5 mlxh-'. Fractions (3 ml) containing inhibitor activity were pooled and freeze-dried after desalting on a column of Sephadex G25.
Electrophoresis
IEF was made with 2% Ampholine, pH 3 -10 (LKB), at 25 ~ in 74• mm polyacrylamide gel rods and staining for inhibition of subtilisin, trypsin and chymotrypsin was made with the chromogenic substrate APNE, as described in detail previously (2) . SDS-PAGE was made in 180•215 mm gel slabs (1, 16).
Amino acid analysis
Acid hydrolysis in 5.7 N-HC1 was made in evacuated sealed tubes for 24 hours and the analysis performed on a Durrum D500 amino acid analyser. Performic acid oxidation was done according to HIRS (4) to check for the presence of cystein or cystine.
Amino acid sequence determination
Determination of the amino acid sequences was performed ~is described previously (5) in a Beckman liquid phase sequenator, model 830. In most cases Polybrene was added together with the sample. Identification of the PTH-amino acids was made by HPLC on a Hewtett-Packard chromatograph, model 1083B as described by SVENDSEN et al. (18) .
Cleavage with cyanogen bromide
Six mg of inhibitor was dissolved in 600 ~tl formic acid (70%) and 70 mg of cyanogen bromide added. The mixture was left overnight in the dark at room temperature, then dried, redissolved in 30% acetic acid and applied to a column ofSephadex GS0 (superfine, 115• 1 cm) equilibrated with 30% acetic acid. One ml fractions were collected with a flow-rate of 3.3 mlxh t.
Digestion with trypsin
The largest cyanogen bromide fragment (2.2 mg) was acetylated at pH 8.0 in 0.6 M-ammoniumbicarbonate by addition of 4• acetic anhydride with intervals of 10 min. After freezedrying the derivative was redissolved in 0.1 M-ethylmorpholine buffer, pH 8.0 and trypsin (treated with diphenylcarbamylchloride) was added in a ratio of 1:100 (W/W). After 4.5 hours at 40 ~ the digest was applied to a Sephadex G50 column and eluted as described in section 2.8.
Digestion with carboxypeptidase
Pertinent peptides were digested with carboxypeptidase Y and B in 0.1 M-N-ethylmorpholine buffer, pH 7 or 5.5, aliquots were withdrawn at suitable time-intervals, acidified, dried and finally applied to the amino acid analyser in a buffer at pH 2.2.
Separation of peptides by HPLC
Peptide mixtures were separated on a C,8 reverse phase column (Waters) using a gradient of n-propanol in 0.1% trifluoro-acetic acid.
Reactive site cleavage
Attempts to identify the reactive site(s) of VSI by cleavage with catalytic amounts of subtilisin Carlsberg at pH 4.5 were made as described for the barley CI inhibitors (6) . Cleavage with about 2 mole% porcine pancreas elastase was made in 0.1 M-ammonium acetate buffer, pH 5.5, for 24 hours at 25 ~ After freeze-drying the incubation mixture was applied directly to the sequencer. Figure 2 ).
RESULTS
Purification
The crude extract contained 140 units of inhibitor corresponding to about 0.15 mgxg' seed. More than 80% of the activity was recovered after ammonium sulfate precipitation (section 2.3). In the first chromatographic step, anion exchange at pH 8.6, the inhibitor activity eluted at about 0.16 M-NaC1 in the gradient in front of the major protein peaks (Figure 1 ). Gelfiltration on a column of Sephadex G50 further separated the inhibitor from a major peak of proteins with higher MW (Figure 2 ). When the pooled active material was subjected to anion exchange at pH 7.5 (section 2.4.3), the inhibitor activity was eluted in an almost symmetrical peak overlapping with a distinct protein peak at about 0.1 M-NaC1 in the gradient. The pooled material ( 14 mg) constitutes the purified inhibitor (VSI) characterized below and corresponds to a recovery of about 37% with an 1100-fold purification. In analytical gel filtration experiments on a long column of Sephadex G75 (section 2.4.4) with 3-4 mg samples of the purified material a symmetrical peak containing all the applied protein and activity was eluted and no increase in the specific activity was obtained.
Physico-chemical properties
The purity of VSI was controlled by PAGE-IEF and SDS-PAGE (Figure 3 ). Protein staining after IEF showed one major band with pI = 4.8 and a minor band with pl = 5.0 ( Figure 3A) . Staining for inhibition of subtilisin showed the same bands ( Figure 3B ), but no trypsin or chymotrypsin inhibitor zones could be detected ( Figure 3C ). In SDS-PAGE the same pattern of one major and one minor band was detected ( Figure 3D ). The major band migrated corresponding to a MW near 11,000, the minor band near MW 8,500, but values obtained for proteins of this size are not always reliable (1). The result is, however, in general agreement with a MW near 10,500 obtained in repeated gel filtration experiments (section 2. 4.4) . In addition to the major inhibitor, the VSI preparation, apparently, contains a minor subtilisin inhibitor with a slightly lower MW, but non-active contaminants could not be detected. The amino acid composition of VSI obtained after 24 hours hydrolysis is given i Table I . Comparison with compositions of the Vigna and Phaseolus inhibitors, which are of the same molecular size (15, 20) , confirms a high degree of similarity (Table  I ). The very low cysteine content o fespecially the Vicia and Vigna inhibitors is characteristic for members of the "potato inhibitor I family" (16).
Specificity of inhibition
Inhibition studies showed that VSI is a strong and relatively specific inhibitor of microbial alkaline proteases. Titration of subtilisin Novo To obtain a MW near 9,000, all three proteins were assumed to contain 80 residues in these recalculations. 3. Trp was not determined, but 1 Trl0 was found during sequencing.
and subtilisin Carlsberg (4x10-TM) with VSI proceeded linearly to almost 100% inhibition, therefore the data obtained did not allow for an estimation of K, values according to the method of GREEN and WORK (3). In similar experiments with technical grade preparations of alkaline proteases from Aspergillus oryzae and Bacillus pumilus the inhibition curve was linear up to at least 90% inhibition. In contrast to the previously sequenced members of this inhibitor family, VSI did not inhibit chymotrypsin. A weak "non-stoichiometric" inhibition of pancreas elastase was found after 5 min preincubation, but the enzyme activity was partially released during the assay. In experiments where VSI was preincubated with elastase for 30 min prior to addition of substrate, no inhibition of pancreas elastase could be detected. Apparently, inhibition was of the "temporary" type first described by LASKOWSK! and Wu (8) . No interaction of VSI with trypsin was observed.
Amino acid sequence
Terminal sequences
An attempt to determine the amino acid sequence directly from the N-terminal failed due to blockage of the N-terminal residue. Treatment of the inhibitor with pyroglutamic acid decarboxylase did not liberate any new N-terminal amino acid which excludes pyroglutamic acid as the N-terminal. A peptide which amounted to approximately 7% of the material applied to the sequencer could, however, be followed 12 steps, giving the sequence: Val-GluGlu-Lys-Ala-Glu-X -Leu-Thr-X -Pro-Asp-.
The electrophoretic characterization ( Figure  3 ) showed no presence of contaminating non-active proteins, and no "background" sequences were detected in the subsequent sequencing of inhibitor fragments (sections 3. 4 
.2 and 3.4.3).
These observations suggest that the above sequence represents the N-terminus of the minor component detected by IEF and SDS-PAGE, and also that this inhibitor represents a molecular form of the same protein as the major component, but with a partially degraded N-terminus. This interpretation is in accordance with experiences from sequencing of the homologous barley CI-2 inhibitor, where both an inhibitor with blocked N-terminus and molecular forms with "ragged" N-termini were identified (17) .
Attempts to determine the carboxyl terminal sequence by digestion with carboxypeptidase Y in the presence of 0.5% SDS (16) or with carboxypeptidase B were unsuccessful.
Cyanogen bromide fragments
Since the amino acid analysis (Table I) showed the presence of methionine (0.2 mol/mol of inhibitor) the inhibitor was treated with cyanogen bromide followed by get filtration on Sephadex G50. The elution pattern showed two major peaks. The peak representing the largest molecular weight contained 80% of the treated material and showed to be uncleaved VSI with blocked N-terminal, but a minor peptide gave the same N-terminal as described in section 3.4.1, The second smaller peak contained a peptide beginning: Pro-Glu-Ala-and it was sequenced 32 steps (Pro23-Lys54 in Figure 4) . However, the amino acid composition of this peak material was compatible with that of the inhibitor itself. Furthermore, the peptide observed in limited amounts in the unmodified VSI was also detected in this sequencer run. Apparently, two peptides of approximately equal length were eluted in the second peak, one of which represented the blocked N-terminal of VSI. The cleavage of 20% of VSl with cyanogen bromide is compatible with a content of 0.2 mole Met/mole of VSI (Table I ) and indicates polymorphism of the inhibitor.
Tryptic peptides
Acetylated VSI was digested with trypsin and the peptides were separated by gel filtration on Sephadex G50. Two peaks detected from measurement of OD280 (A and B) were followed by two peptide peaks (C and D), identified only by spot test for Arg. The front peak A was sequenced 22 steps starting with Lys,7 ( Figure  4) . A Lys was identified in step 6, an observation not compatible with Met in position 22 as deduced from the cyanogen bromide sequence (section 3.4.2). Furthermore, Asp was identified in step 17 (position 33) which was occupied by a Gly in the overlapping cyanogen bromide fragment. The most plausible explanation of these findings appears to be that at least two genetic variants of VSI are present in the preparation: One containing the residues Argjr, Lys22, and Asp33, while the other molecular form with Met_,, and Gly33 may contain another residue X,6, not allowing for tryptic cleavage.
The second peak B from the gelfiltration contained two peptides with free terminals. One peptide started with Leu47 ( Figure 4 ) and disappeared after eight steps at the same position as the cyanogen bromide fragment. The second peptide was followed 14 steps. Comparison with sequences of inhibitors from the same family ( Figure 5 ) shows that this peptide corresponds to residues Thr_~-Ala,5 in Figure 4 . The precedent residue must be Arg., since the acetylated lysines were unaccessible to trypsin.
Separation of the peak B material by HPLC resulted in isolation of three major peptides (B-5, B-6 and B-10). Digestion of peptide B-5 with carboxypeptidase Y liberated Val and Arg in the molar ratio 2:1. With this information the amino acid composition of B-5 (Table II) is compatible with the peptide previously sequenced from position 47 (Leu47-Arg57). Although this peptide contains three Val, while only two residues were found by amino acid analysis, it is well-known that a Val-Val sequence drastically decreases the rate of Val released during hydrolysis in 6 M-HC1. The amino acid composition of the peptide B-10 (Table II) is compatible with the other sequenced peptide (Thr,-Arg~6). The composition of the third major peptide B-6 (Table II) derived from peak B does not cover any of the sequences determined so far. However, only two N-terminal sequences were detected when the peak B peptide mixture was sequenced and therefore peptide B-6 most likely represents the 12-14 N-terminal residues of VSI. The amino acid composition of B-6 agrees fairly well with the minor sequence obtained by direct sequencing of the VSI preparation (section 3.4.1 )but since overlap between this sequence and the sequence starting at Arg, (Figure 4) was not established the final proof is lacking.
One of the peaks located by Arg spot test (peak D) was separated into three small peptides by HPLC. The amino acid composition of the dipeptide D-2 (Table If) Table I , except for the single His, which was not observed in any of the sequenced steps.
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Reactive site(s)
Calculations from the inhibition experiments with subtilisins (section 3.3) showed a molar ratio of 1:1 in the complex formed. Reactive sites in other inhibitors have been identified by cleavage at low pH with catalytic amounts of the enzyme inhibited (6, 7, 11, 13, 14, 15) . Attempts to identify a reactive site for subtilisin Carlsberg by this technique were, however, unsuccessful. The "temporary" inhibition of pancreas elastase suggested a proteolytic modification of VSI by this enzyme (section 3.3). When VSI was treated with elastase in similar experiments and applied to the sequencer directly after incubation, a mixture of three peptides in almost equal quantities could be identified as: SerH-Alat2-Glu~3-Gluta-Ala~5-, Asp~9-Tyra0-Lys41-Phe42-, and Argn6-Leu47-Tyr48-Va149-Asps0- (Figure 4 ). The cleavage of the three bonds Valt0-Ser~t, Ala38-Asp39 and Va145-Arg46 is in accordance with the specificity of elastase.
DISCUSSION
Although the N-terminal sequence of VSI was not determined, comparisons clearly confirm that VSI belong to the"potato inhibitor I family" of homologous inhibitors (7) . In the comparable part of the sequences (residues 21-71, Figure  5 ) 56%, 46%, 42%, and 36% of the residues in VSI were found in the same positions as in C1-2, CI-I, PM and LIE, respectively. The similar amino acid compositions (Table I) and isoelectric patterns (2) strongly suggest that inhibitors of this family are widespread in seeds of leguminous plants. The wide distribution in the plant kingdom and the homology with the animal inhibitor leech eglin may suggest a universal distribution.
Previously sequenced inhibitors were present in a number of molecular forms due to both genetic variants and "ragged" N-terminals, and during purification it was difficult to separate them completely (1, 16, 17) . Similar observations were made during the present study. Although VSI was isolated in an apparently pure form, the preparation contained the same mixture of one major and one minor form as the crude extract (2). The major form had a blocked N-terminal, as one of the barley CI-2 inhibitors (17, 18) , and at least two genetic variants were detected. Only monomer forms of VSI were detected during purification, in contrast to the strong tendency of the barley and potato inhibitors to form dimer and/or tetramer aggregates (1, 10, 11).
The major cleavage point for chymotrypsin and/or subtilisin, which is assumed to represent the reactive site P,-P] bond, was identified in the same position between residues 60 and 61 ( Figure 5 ) in all the four previously sequenced inhibitors (6, 11, 13) . They all have a large hydrophobic amino acid (Met60 or Leu60) in the P~ position. The presence of Ala60 in VSI may explain why VSI is not reacting with chymotrypsin, but still is a strong inhibitor of subtilisins. This finding also suggests a specificity for elastases (7), but only a weak "non-stoichiometric" inhibition of porcine pancreas elastase was found. Ala was also detected in the assumed P~ position of the Phaseolus inhibitor (14, 15) , which was a strong inhibitor of both subtilisin and leukocyte elastase, but the latter enzyme was not included in the present study.
The assumed reactive site bond Alar0-Aspr, was among the three sites in VSI cleaved by catalytic amounts of pancreas elastase. One of the other cleavage points was at Val30-Ser3~ ( Figure 5 ). Cleavage in barley inhibitor CI-1 (6) with catalytic amounts of subtilisin suggested Met30-Ser~ as a second subtilisin reactive site. The amino acid sequence around this position seems to be highly conserved, but whether it is a truely inhibitory binding site remains to be resolved. The present inhibition studies suggested a molar ratio of 1:1 in the VSI-subtilisin complex. The third elastase sensitive bond at Va167-Arg68 is close to the assumed binding site at Ala60-Asp6~. Cleavage at this position may explain why VSI only functions as a temporary inhibitor of pancreas elastase.
